Moolec Science
self owned molecular biology lab | Moolec Science
Company
Deck Type
Deck date
December 2023
Slide
11 of 20
Related slides by other companies
Absci
Investor Presentation
October 2022
is merging synthetic biology to accelerate biologic drug creation | Absci
Alkermes
Investor Day
March 2021
alkermes molecular design biology rationale commercial opportunity unmet need high value development candidate strong biology rationale capabilities focused within defined scientific platforms targets externally validated and vetted with scientific advisors potential opportunity for first in class or best in class therapies structure activity insight guides molecular design regulatory pathway technical feasibility technical feasibility clinical pathway integrated capabilities in medicinal chemistry protein engineering and molecular modeling utilized to address technical challenges | Alkermes
Other recent decks by Moolec Science
See all presentations (5 decks)
Results
March 2024
Investor Presentation
August 2023
Results
May 2023
SPAC
June 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io